In addition, previous studies have reported that MYC negatively regulates the expression of miR-34a-5p in multiple myeloma (Xiao et al., 2019), and YY1 levels are inversely related to miR-155 in atherogenesis (Tian et al., 2014). The gene discussed is MYC; the disease is plasma cell myeloma.